Concepedia

Publication | Open Access

BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression

DOIFull Paper Access

37

Citations

37

References

2022

Year

Ilana Mandel, Dana Haves Ziv, Ilana Goldshtein, Tsuri Peretz, Dror Alishekevitz, Anna Fridman Dror, Motti Hakim, Sharon Hashmueli, Itay Friedman, Yair Sapir,
Journal for ImmunoTherapy of Cancer

Abstract

NCT04717375.

References

YearCitations

Page 1